Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to 0.01.

  • Pharma's Debt Ratio rose 406.01% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 406.01%. This contributed to the annual value of 0.02 for FY2025, which is 1072.56% up from last year.
  • Per Pharma's latest filing, its Debt Ratio stood at 0.01 for Q3 2025, which was up 406.01% from 0.02 recorded in Q2 2025.
  • Pharma's Debt Ratio's 5-year high stood at 0.02 during Q2 2025, with a 5-year trough of 0.0 in Q2 2021.
  • Moreover, its 5-year median value for Debt Ratio was 0.01 (2023), whereas its average is 0.01.
  • Over the last 5 years, Pharma's Debt Ratio had its largest YoY gain of 83739.2% in 2021, and its largest YoY loss of 8043.82% in 2021.
  • Quarter analysis of 5 years shows Pharma's Debt Ratio stood at 0.0 in 2021, then surged by 48.52% to 0.01 in 2022, then soared by 74.46% to 0.01 in 2023, then rose by 20.43% to 0.01 in 2024, then decreased by 8.22% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.02 for Q2 2025, and 0.02 during Q1 2025.